Neptune Technologies & Bioressources Company Profile (TSE:NTB)

Analyst Ratings

Consensus Ratings for Neptune Technologies & Bioressources (TSE:NTB) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Neptune Technologies & Bioressources (TSE:NTB)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Neptune Technologies & Bioressources (TSE:NTB)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
10/12/2016        
7/16/2014($0.08)($0.06)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/22/2014($0.08)($0.08)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Neptune Technologies & Bioressources (TSE:NTB)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Neptune Technologies & Bioressources (TSE:NTB)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Neptune Technologies & Bioressources (TSE:NTB)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
2/1/2016James Stuart HamiltonDirectorBuy4,000C$1.58C$6,320.00Tweet This Trade  Share This Trade on StockTwits
1/28/2016James Stuart HamiltonDirectorBuy2,000C$1.55C$3,100.00Tweet This Trade  Share This Trade on StockTwits
1/18/2016Mario ParadisInsiderBuy10,000C$1.50C$15,000.00Tweet This Trade  Share This Trade on StockTwits
1/15/2016John Morris MoretzDirectorBuy700,651C$1.05C$735,683.55Tweet This Trade  Share This Trade on StockTwits
1/15/2016Mario ParadisInsiderBuy40,000C$1.54C$61,672.00Tweet This Trade  Share This Trade on StockTwits
10/29/2015John Morris MoretzDirectorBuy26,044C$1.08C$28,101.48Tweet This Trade  Share This Trade on StockTwits
10/28/2015John Morris MoretzDirectorBuy24,500C$1.12C$27,538.00Tweet This Trade  Share This Trade on StockTwits
10/27/2015John Morris MoretzDirectorBuy5,500C$1.09C$6,006.00Tweet This Trade  Share This Trade on StockTwits
10/23/2015John Morris MoretzDirectorBuy50,000C$1.17C$58,385.00Tweet This Trade  Share This Trade on StockTwits
10/5/2015John Morris MoretzDirectorBuy13,692C$1.24C$16,991.77Tweet This Trade  Share This Trade on StockTwits
10/2/2015John Morris MoretzDirectorBuy33,900C$1.23C$41,663.10Tweet This Trade  Share This Trade on StockTwits
9/15/2015John Morris MoretzDirectorBuy9,001C$1.24C$11,161.24Tweet This Trade  Share This Trade on StockTwits
7/22/2015John Morris MoretzDirectorBuy2,800C$1.34C$3,750.60Tweet This Trade  Share This Trade on StockTwits
7/21/2015John Morris MoretzDirectorBuy21,654C$1.34C$28,975.22Tweet This Trade  Share This Trade on StockTwits
7/16/2015Pierre LemieuxDirectorSell6,250C$1.62C$10,135.00Tweet This Trade  Share This Trade on StockTwits
6/8/2015Pierre FitzgibbonDirectorBuy47,500C$1.70C$80,693.00Tweet This Trade  Share This Trade on StockTwits
2/17/2015Reed TucksonDirectorBuy10,800C$1.85C$19,931.40Tweet This Trade  Share This Trade on StockTwits
2/13/2015Michel TimperioInsiderSell10,000C$2.19C$21,870.00Tweet This Trade  Share This Trade on StockTwits
2/6/2015André GodinInsiderSell5,000C$2.14C$10,700.00Tweet This Trade  Share This Trade on StockTwits
2/5/2015Michel TimperioInsiderSell15,000C$2.11C$31,680.00Tweet This Trade  Share This Trade on StockTwits
1/30/2015Bel Dominique LeInsiderSell15,000C$2.30C$34,500.00Tweet This Trade  Share This Trade on StockTwits
1/29/2015Bel Dominique LeInsiderSell10,000C$2.25C$22,500.00Tweet This Trade  Share This Trade on StockTwits
1/22/2015Claudie LauzonInsiderSell8,334C$2.04C$16,966.36Tweet This Trade  Share This Trade on StockTwits
1/22/2015Pierre LemieuxDirectorSell11,250C$2.00C$22,500.00Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Neptune Technologies & Bioressources (TSE:NTB)
DateHeadline
07/15/16 11:26 AMAcasti Announces the Election of its Directors, Change of Fiscal Year End and Other Related Matters Passed at its AGM - [Marketwired] - Acasti Pharma Inc. of new krill oil-based forms of omega-3 phospholipid therapies for the treatment of hypertriglyceridemia, announced that the nominees listed in its management proxy circular dated June ...
07/12/16 10:48 AMEdited Transcript of NTB.TO earnings conference call or presentation 12-Jul-16 12:00pm GMT -
07/12/16 09:50 AMGeneral Mills Inc said late Monday it is recalling one of its Betty Crocker brand cake mixes from Canadian markets because of a possible E
07/12/16 09:50 AMNeptune Announces First Quarter Results
07/11/16 05:31 PMNeptune Announces First Quarter Results / Record Revenues and EBITDA for the Quarter in the Nutraceutical Segment
07/11/16 05:31 PMNeptune Technologies & Bioressources : Announces First Quarter Results
07/11/16 06:07 AMQ1 2017 Neptune Technologies & Bioressources Inc Earnings Release - After Market Close -

Social

About Neptune Technologies & Bioressources

Neptune Technologies & Bioressources Inc is a Canada-based biotechnology company. The Company is engaged primarily in the development, manufacture and commercialization of marine-derived omega-3 polyunsaturated fatty acids (PUFAs). The Company has three operating segments: Neptune, Acasti Pharma Inc. and NeuroBioPharm Inc. The Company's Neptune segment produces and commercializes nutraceutical products. The Company's Acasti Pharma Inc. segment develops and commercializes medical food and pharmaceutical products for cardiovascular diseases. The Company's NeuroBioPharm Inc. segment develops medical food and pharmaceutical products for neurological diseases. The Company's lead product, Neptune Krill Oil (NKO), come in capsule form and serve as a dietary supplement to consumers. The Company's other nutraceutical products include Ecokrill Oil (EKO), Rimfrost Oil, Neptune Krill Aquatein ( NKA) and New Formulation Derived from NKO, which include NKO Beat, NKO Flex and NKO Focus.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: TSE
  • Symbol: NTB
  • CUSIP:
Key Metrics:
  • Previous Close: $1.42
  • 50 Day Moving Average: $1.36
  • 200 Day Moving Average: $1.41
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $109.12M
  • Current Year EPS Consensus Estimate: $0.01 EPS
  • Next Year EPS Consensus Estimate: $N/A EPS
Additional Links:
Neptune Technologies & Bioressources (TSE:NTB) Chart for Saturday, July, 23, 2016